Oocyte donors | Infertile patients | |||||||
---|---|---|---|---|---|---|---|---|
Total | Caucasian | African | Asian | Total | Caucasian | African | Asian | |
(n = 62) | (n = 46) | (n = 10) | (n = 6) | (n = 536) | (n = 373) | (n = 81) | (n = 82) | |
Age(years) | 24.1 ± 3.71 | 24.2 ± 4.0 | 23.8 ± 2.2 | 23.7 ± 4.2 | 37.5 ± 5.21 | 37.8 ± 5.0 | 37.8 ± 5.3 | 36.1 ± 6.1 |
BMI(kg/m 2 ) | 21.0 ± 2.82 | 20.6 ± 2.6 | 22.3 ± 2.8 | 21.5 ± 4.1 | 24.5 ± 5.12 | 24.5 ± 5.3 | 26.8 ± 5.1 | 22.2 ± 3.1 |
Estradiol(pg/mL) | 51.5 ± 26.1 | 52.5 ± 27.7 | 49.0 ± 19.4 | 46.2 ± 21.6 | 55.0 ± 37.8 | 57.0 ± 40.2 | 51.9 ± 34.5 | 48.8 ± 27.5 |
FSH(mIU/mL) | 6.8 ± 2.93 | 6.7 ± 3.0 | 6.6 ± 1.5 | 8.2 ± 2.8 | 12.3 ±10.13 | 12.5 ± 10.2 | 13.8 ± 13.4 | 10.2 ± 4.1 |
AMH(ng/mL) | 4.5 ± 2.94 | 4.3 ± 3.0 | 5.7 ± 1.9 | 4.6 ± 3.7 | 1.7 ± 2.24 | 1.6 ± 1.95 | 2.0 ± 2.9 | 2.3 ± 2.45 |
Oocyte yield | 17.7 ± 7.76 | 16.7 ± 6.67 | 23.7 ± 10.47,8 | 14.8 ± 6.48 | 8.1 ± 6.76 | 8.1 ± 6.8 | 7.9 ± 7.3 | 8.1 ± 5.9 |
FMR1 n (%) | ||||||||
norm | 33 (53.2) | 26 (56.5) | 4 (40.0) | 3 (50.9) | 315 (58.8) | 218 (58.4) | 41 (50.6) | 56 (68.3) |
het-norm/high | 6 (9.7) | 3 (6.5) | 1 (10.0) | 2 (33.3) | 86 (16.0) | 51 (13.7) | 18 (22.2) | 17 (20.7) |
het-norm/low | 19 (30.6) | 14 (30.4) | 5 (50.0) | 0 (0.0) | 107 (20.0) | 83 (22.3)9 | 19 (23.5)9 | 5 (6.1)9 |
hom | 4 (6.5) | 3 (6.5) | 0 (0.0) | 1(16.7) | 28 (5.2) | 21 (5.6) | 3 (3.7) | 4 (4.9) |
Primary infertility diagnosis n (%) | ||||||||
DOR | N/A | N/A | N/A | N/A | 279 (52.1) | 199 (47.5) | 38 (47.5) | 42 (51.2) |
Male factor | N/A | N/A | N/A | N/A | 134 (25.0) | 96 (25.7) | 18 (22.5) | 20 (24.4) |
Tubal Disease | N/A | N/A | N/A | N/A | 105 (19.6) | 70 (16.7) | 23 (25.3) | 12 (13.6) |
Endometriosis | N/A | N/A | N/A | N/A | 27 (5.0) | 21 (5.6) | 1 (1.3) | 5 (6.1) |
Uterine factors | N/A | N/A | N/A | N/A | 36 (6.7) | 20 (5.3) | 1 (1.2) | 15 (18.8) |
PCOS | N/A | N/A | N/A | N/A | 39 (7.3) | 27 (7.2) | 6 (7.5) | 6 (7.3) |